Treatment Outcome With Antibiotic Use and Its Resistance Pattern Among Patient With Neonatal Sepsis
NCT05742477 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-02-24
Summary
Determine Treatment outcome with antibiotic use and its resistance pattern among neonatal sepsis patients
Conditions
- Neonatal Sepsis
Interventions
- DRUG
-
Antibiotic
role of antibiotics in treatment of neonatal sepsis
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 1 Day
- Max Age
- 28 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-31
- Primary Completion
- 2024-12-01
- Completion
- 2024-12-31
More Related Trials
-
Prognostic Value of Complete Blood Count in Severe Infections
NCT03685071 ·Status: UNKNOWN
-
Early Identification and Effective Management of Pediatric Sepsis
NCT03996720 ·Status: COMPLETED
-
The Impact of Sepsis on Long-term Outcomes in Critical Ill Children With Sepsis
NCT06323226 ·Status: RECRUITING
-
Pharmacokinetics and Pharmacodynamics of High Dose Ceftriaxone in Patients With Sepsis
NCT07245966 ·Status: COMPLETED
-
7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis
NCT03280147 ·Status: COMPLETED ·Phase: PHASE3
-
White Blood Cells and Platelets Indices as a Prognostic Factor in Neonatal Sepsis
NCT03880305 ·Status: UNKNOWN
-
Simplified Antibiotic Therapy for Sepsis in Young Infants
NCT01027429 ·Status: COMPLETED ·Phase: PHASE3
-
Early Diagnosis of Neonatal Sepsis
NCT04105413 ·Status: UNKNOWN
-
Retrospective Examination of Initial Care of Severe Bacterial Infections of the Child
NCT01485705 ·Status: COMPLETED ·Phase: NA
-
Evaluation of bioMarkErs to Reduce Antibiotics Use in hospitalizeD nEonates
NCT03299751 ·Status: COMPLETED ·Phase: NA
-
Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children
NCT03441126 ·Status: COMPLETED
-
Procalcitonin in Diagnosis of Bacterial Infections in Young Infants
NCT03509727 ·Status: COMPLETED
-
Establishment of Early Diagnosis and Monitoring Model for Sepsis Patients
NCT04974411 ·Status: UNKNOWN
-
Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients
NCT03344627 ·Status: COMPLETED ·Phase: NA
-
Resuscitation Failure, Oxidative Stress, and Necroptosis as Mortality Predictor in Septic Patient
NCT04169412 ·Status: COMPLETED
-
Simplified Antibiotic Regimens for Outpatient Treatment of Suspected Sepsis in Neonates and Young Infants in Bangladesh
NCT00844337 ·Status: COMPLETED ·Phase: NA
-
Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit
NCT03217721 ·Status: COMPLETED
-
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
NCT04105400 ·Status: UNKNOWN
-
Neutrophil Extracellular Traps and Neonatal (PV4991) & Pediatric Sepsis (PV5063)
NCT02567305 ·Status: UNKNOWN
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
Analysis of Differential Proteins and Maternal Influencing Factors of Septic Shock in Neonates
NCT06206590 ·Status: RECRUITING
-
A Machine Learning Predictive Model for Sepsis
NCT04771429 ·Status: UNKNOWN
-
Procalcitonin Monitoring May Decrease Antibiotic Use in the Intensive Care Unit
NCT01085994 ·Status: UNKNOWN
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Early Lactate Clearance Rate in Sepsis
NCT04192279 ·Status: UNKNOWN